Winton Group’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,784
Closed -$1.45M 1256
2021
Q3
$1.45M Buy
4,784
+832
+21% +$236K 0.08% 322
2021
Q2
$1.07M Buy
3,952
+866
+28% +$220K 0.06% 492
2021
Q1
$751K Buy
3,086
+491
+19% +$135K 0.04% 636
2020
Q4
$744K Sell
2,595
-90
-3% -$24.8K 0.05% 571
2020
Q3
$684K Buy
+2,685
New +$638K 0.02% 980
2019
Q4
Sell
-12,019
Closed -$2.86M 1686
2019
Q3
$2.86M Buy
12,019
+7,749
+181% +$1.79M 0.03% 442
2019
Q2
$1.04M Buy
+4,270
New +$994K 0.02% 403
2019
Q1
Sell
-1,734
Closed -$361K 1138
2018
Q4
$361K Buy
+1,734
New +$338K 0.01% 595

Other funds holding MLAB

Winton Group's MLAB Position: Q4 2021 in Review

Winton Group sold out of Mesa Laboratories (MLAB) in Q4 2021, closing a stake of 4,784 shares — an estimated $1.45M sold.

Winton Group first reported a position in MLAB in Q4 2018 and held it in 8 quarters. The position peaked at $2.86M in Q3 2019. 178 funds tracked by Wall St. Rank hold MLAB as of Q4 2021.

  • Winton Group reported no remaining Mesa Laboratories position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 4,784 Mesa Laboratories shares in Q4 2021, an estimated $1.45M.
  • Winton Group first reported a position in Mesa Laboratories in Q4 2018 and held it in 8 quarters.
  • Winton Group's Mesa Laboratories position peaked at $2.86M in Q3 2019.
  • 178 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.